CIK 0001671584
- Non-accelerated filer
- Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811567056
- Phone
- +1 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | Adelman Michael SVP, Commercial Operations | Grant or award · Stock Option (right to buy) | +134,800 | 134,800 | ||
| 2019-11-01 | Adelman Michael SVP, Commercial Operations | Grant or award · Stock Option (right to buy) | +114,247 | 114,247 | ||
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Exercise or conversion | +7,318 | 72,821 | ||
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Shares withheld for taxes | −2,395 | $1.57 | $4K | 70,426 |
| 2019-03-01 | Adelman Michael SVP, Commercial Operations | Exercise or conversion · Restricted Stock Unit | −7,318 | 0 | ||
| 2019-02-28 | Adelman Michael SVP, Commercial Operations | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 |
Page 1 of 1 · 6 trades